Bioventus (BVS) Profit After Tax Growth (3y) (2023 - 2026)
Bioventus (BVS) Profit After Tax Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 49.66% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -7.65% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 9.79% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 97.37% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 15.46% |
| 10 | Bioventus | 969.51 Mn | 940.05 Mn | 105.67 Mn | 114.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 114.72% |
| Mar 28, 2026 | 26.32% |
| Dec 31, 2025 | -14.93% |
| Sep 27, 2025 | 27.14% |
| Jun 28, 2025 | 48.19% |
| Mar 29, 2025 | 38.39% |
| Dec 31, 2024 | -26.02% |
| Sep 28, 2024 | -25.15% |
| Jun 29, 2024 | -103.53% |
| Mar 30, 2024 | -83.01% |
| Dec 31, 2023 | -78.26% |
| Sep 30, 2023 | -45.87% |
| Jul 1, 2023 | 13.90% |
| Apr 1, 2023 | -161.49% |